A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology.

scientific article

A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1013269463
P356DOI10.1186/BCR1013
P932PMC publication ID1143561
P698PubMed publication ID15987434
P5875ResearchGate publication ID7757378

P50authorAnn AschengrauQ43184014
P2093author name stringBrian D Bradbury
Jemma B Wilk
Timothy L Lash
P2860cites workPerchloroethylene-contaminated drinking water and the risk of breast cancer: additional results from Cape Cod, Massachusetts, USAQ24813464
Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expressionQ28116125
N-acetyltransferaseQ28270778
Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liverQ33190344
Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liverQ33493879
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphismsQ33833591
Epidemiological methods for studying genes and environmental factors in complex diseasesQ34421625
DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke.Q34637005
Tobacco and cancer: epidemiology and the laboratoryQ34834385
Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesisQ34914587
Cigarette smoking and the risk of breast cancer in women: a review of the literatureQ34958954
Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylationQ35228461
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activityQ35643631
Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case-Control Study GroupQ36079437
Molecular mechanism of slow acetylation of drugs and carcinogens in humansQ37532218
Diverse point mutations in the human gene for polymorphic N-acetyltransferaseQ37552468
Acetylator genotype and arylamine-induced carcinogenesisQ39653636
Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focusQ40406973
Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology.Q40530680
Toward a physiological approach to breast cancer prevention.Q40689523
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.Q40857024
Cigarette smoking and the risk of breast cancerQ40862130
Molecular epidemiology of breast cancer.Q41435039
Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer.Q44012104
NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking womenQ44497812
Preliminary phenotypic map of chromosome 4p16 based on 4p deletions.Q45992148
Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferasesQ50336069
Relation of breast cancer with passive and active exposure to tobacco smoke.Q52887337
Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants.Q54261668
Active and Passive Cigarette Smoking and the Occurrence of Breast CancerQ57240454
A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancerQ57982063
Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogensQ59094252
Passive and active smoking and breast cancer risk in Canada, 1994-97Q64130676
The effect of misclassification in the presence of covariatesQ71347668
NAT2*12A (803A-->G) codes for rapid arylamine n-acetylation in humansQ71533220
Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer riskQ71748553
Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-AmericansQ72228915
Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotypeQ74136959
Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer riskQ74578010
Limitations of the case-only design for identifying gene-environment interactionsQ74599234
P433issue3
P407language of work or nameEnglishQ1860
P921main subjecttobacco smokeQ2386268
P304page(s)R385-93
P577publication date2005-03-21
P1433published inBreast Cancer ResearchQ2208481
P1476titleA case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology.
P478volume7

Reverse relations

cites work (P2860)
Q37440644Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations
Q35353824Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study
Q37434505N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.
Q36838165Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.